29In addition to prescription drugs, Maruho is challenging itself to create new value closely in tune with people’s skin concerns, from presymptomatic to diagnosis, treatment, prevention, and aftercare, through products and services other than prescription drugs, i.e., diagnostic drugs, medical devices, cosmetics, and others.Maruho is taking on the challenge of cultivating and deepening its presence in the in-vitro diagnostic pharmaceuticals market centered on skin diseases.Launch of DermaQuick HSVMaruho launched DermaQuick HSV, a detection kit for herpes simplex, in February 2023. Herpes simplex is an infection caused by the herpes simplex virus (HSV), which is characterized by recurring symptoms. When it appears, herpes simplex causes small reddish blisters and tingling pain, affecting both the patient’s physical and mental wellbeing. Since early medication is important for the treatment of herpes simplex, a simple and rapid test that diagnose the condition on an outpatient basis is required. DermaQuick HSV provides a finding in 5 to 10 minutes using a specimen taken from a blister and assists in an appropriate diagnosis. Following on from DermaQuick HSV, we aim to develop products that contribute to the appropriate diagnosis and treatment of skin diseases through the introduction of new technologies.Maruho aims to further improve the patients’ Quality of Life by identifying their needs as well as developing and improving products.Launch of Renail GelIn April 2023, Maruho launched the prescription drug Renail Gel to aid in the correction of pincer nails. Pincer nails are a condition where the toe nail or finger nail curls inwards, causing pain and inflammation. Treatment with a corrector usually takes three to six months, but by using Renail Gel concomitantly, the treatment period can be shortened and the corrective effect can be maintained after the corrector is removed. 3. Strategy for Value Creation Progress of the Medium-Term PlanScreenshot of the “Don’t Tolerate Pincer Nails Project” websiteMaruho Report 2023Maruho offers new proposals for daily skin care closely in tune with individual skin troubles.Launched three novel items under Carté HDIn March 2023, Maruho launched three items in the “Dry Skin Balance Care” line under the quasi-pharmaceutical high-performance skincare brand Carté HD offered by Kose Maruho Pharma Co., Ltd. By adding acne prevention to the conventional function of high moisturizing effect, these items support skin care for people who suffer from both dryness and oily skin.Advanced Barrier Day Essence receives award from popular magazineNew products in the iniks brandMaruho’s skincare cosmetics brand iniks was born from the voices of medical professionals who treat skin problems. Launched in March 2023, Advance Barrier Day Essence, a sunscreen serum that protects sensitive skin from ultraviolet rays, has been highly evaluated. The product has received awards from several popular magazines, including the Sunscreen Award in the LEE’s Best Cosmetics 2023 SS (the First Half).1 Diagnostic drugs2 Medical devicesLaunch of the “Don’t Tolerate Pincer Nails Project” Pincer nails are a condition that is not well known and people tend to tolerate it even if it hurts. As part of our efforts to raise awareness of this condition, in July 2023, Maruho launched the “Don’t Tolerate Pincer Nails Project” to encourage people to treat their pincer nails.3 CosmeticsTogether with MAKIZUME MEISTER, the pincer nail corrector which we manufacture and market in-house, we contribute to the treatment of patients suffering from pincer nails.Renail GelAdvance Barrier Day EssenceDermaQuick HSVThree items from “Dry Skin Balance Care”Maruho’s cosmetics website called “Skin & Beauty Information by Maruho”Business activities outside of prescription drugs
元のページ ../index.html#30